Events Partner Content 14th Annual Pre-Filled Syringes and Drug Devices 2022 The Future of Drug Delivery and Combination Products
Partner Content Partner Content Regulatory Issues for PF Syringes & Injectable Drug Devi... Pre-Filled Syringes & Injectable Drug Devices Europe
Partner Content Partner Content Full Agenda Released for Pre-Filled Syringes & Injectabl... The Future of Drug Delivery & Combination products
Events Partner Content Pre-Filled Syringes & Injectable Drug Devices Europe SMi is proud to present their 11th annual European
News NICE turns down Takeda colorectal cancer drug Takeda's recently approved advanced colorectal cancer therapy Fruzaqla has been rejected by NICE for use by the NHS on the grounds that it is not cost-effective.
Sales & Marketing Sponsored Global reach, personal touch: Mastering customer engagement ... In today's interconnected pharma market, the ability to scale engagement across borders is essential for survival and growth.
